It is widely recognized within the pharmaceutical and medical device industries that there is a distinct competitive advantage that comes with being first to market. Every month of lead time ahead of a competitor is meaningful, as first-movers usually acquire significantly greater market share in the long run. As such, clinical research sponsors seek to expedite the clinical trial process as much as possible, and they look for contract research organizations (CROs) that can complete studies rapidly while maintaining accuracy.
PharPoint Research, a North Carolina based CRO, sets itself apart from the competition by consistently meeting tight deadlines for its customers. Handling studies across all phases and therapeutic areas, PharPoint utilizes Medrio to support its rapid Phase I operations. Medrio’s simple, fast, and affordable electronic data capture (EDC) software meets strict regulatory standards and fits within limited Phase I budgets.